Impedance Cardiography to Decrease the Risk of Preeclampsia

• Status: Withdrawn
• Trial end date: 2020-02-29
• Target enrollment: 0
• Participant gender: Female

Summary

To determine if the use of impedance cardiography can identify appropriate medications for use in treating chronic hypertensive patients to decrease the risk of preeclampsia.

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: High Risk Obstetrical Consultants; University of Tennessee Medical Center
• Treatments: Atenolol; Labetalol; Nifedipine

Criteria

Inclusion Criteria:

Pregnant patients 18-51 years old Less than 20 weeks gestation with mild chronic hypertension - Not on antihypertensive medications

Exclusion Criteria:

Patients with an allergy to antihypertensive medication or contraindication for their usage such as certain cardiac or neurologic disorder during pregnancy Patients who have a blood pressure 140/90 or greater -